However, a recent study has demonstrated that a strong up-regulation and release of S100A4 was observed in the upper dermis of psoriatic skin, and blocking antibodies against S100A4 resulted in a significant reduction of psoriatic inflammation in a human psoriasis xenograft SCID mouse model [31]. This evidence concerns the gene S100A4 and psoriasis.